FIGNL2 divergent transcript (FIGNL2-DT)

FIGNL2 divergent transcript (FIGNL2-DT) is a long non-coding RNA (lncRNA) gene. It does not encode a protein and is classified as an RNA gene, specifically a member of the lncRNA class[5]. Its genomic locus is chromosome 12:51847065-51852729 (hg38)[3]. There is currently no published evidence of biological function, disease association, or direct therapeutic relevance for FIGNL2-DT. It is not considered a therapeutic target such as a receptor, enzyme, transporter, or transcription factor[5]. This distinguishes FIGNL2-DT from its protein-coding paralog Fidgetin-like 2 (FIGNL2), which is a microtubule-severing ATPase involved in cell migration and development[1][2]; however, FIGNL2-DT itself is not known to have such roles. There are no documented interactions with drugs, no known mechanisms of action, and no associated biomarkers or safety concerns for patient selection or monitoring. The available information is limited to basic gene identification data, and the lack of functional annotation or disease linkage suggests that either the transcript is poorly characterized, or, as of current knowledge, not an established therapeutic target[5][3]. Key clarifications: - FIGNL2-DT is a non-coding RNA gene (lncRNA)[5], not a protein-coding gene or a classic molecular target. - Not suitable as a therapeutic target or mechanism for drug action. - No data on function, disease involvement, or drug interactions. If FIGNL2-DT was intended as a protein-coding target or receptor, this is likely an incorrect or misunderstood designation. The protein-coding paralog, Fidgetin-like 2 (FIGNL2), is distinctly different and has described biological roles[1][2].

Other names

FIGNL2-DTFIGNL2 Divergent Transcript